CAF-603

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCAF-603
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antifungals
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBrazil
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive Companies +[1]  N/A
Active IndicationsN/A
Inactive IndicationsMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A